|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multiple-dose pharmacokinetics,pharmacodynamics and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 2 | Multipledose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reduetase, in healthy subjects 显示文摘 | CILLA DD WHITEFIELD LR GIBSON DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 3 | Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats显示文摘 | Gibson RJ Keefe DM Thompson FM | 2002 | Dig Dis Sci2002，47，12： | 1 |
| 4 | Variability in the attainment of functional milestones during the acute care admission after total joint replacement 显示文摘 | Zavadak KH Gibson KR Whitley DM | 1995 | J Rheumatol1995，22，3： | 1 |
| 5 | Hepatitis B and C virus infections and anti-tumor necrosis factor- alpha therapy: guidelines for clinical approach 显示文摘 | Nathan DM Angus PW Gibson PR | 2006 | J Gastroenterol Hepatol2006，21，9： | 1 |
| 6 | Effect of age and gender on pharmacokinetics of atorvastatin in humans显示文摘 | Bron NJ Richens A | 1996 | Clin Pharmacol1996，36，3： | 1 |
| 7 | Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening显示文摘 | Gibson DM Whitfield LR | 1996 | Clin Pharmacol1996，36，7： | 1 |
| 8 | Direct vascular and cardioprotective effects of rosuvastatin,a new HMG-CoA reductase inhibitor显示文摘 | Jones SP Gibson MF Rimmer DM 3rd | 2002 | J Am Coll Cardiol2002，40，： | 1 |
| 9 | Toxicology ofvindesine (desacetyl vinblastine amide) in mice,rats,and dogs显示文摘 | Todd GC Gibson WR Morton DM | 1976 | J Toxicol Environ Health1976，1，5： | 1 |
| 10 | The effec of keratinocyte growth factor on tumor growth and small intestinal mucositis after chemotherapy in the rat with breast cancer显示文摘 | Gibson RJ Keefe DM Clarke JM | 2002 | Cancer Chemother Pharmacol2002，50，： | 1 |
| 11 | Effect of age and gender on pharmacokinetics of atorvastatin in humans显示文摘 | Gibson DM Bron NJ Richen A | 1996 | J Clin Pharmacol1996，36，： | 1 |
| 12 | Cancer chemotherapy - induced diarrhoea and constipation: mechanisms of damage and p revention strategies 显示文摘 | Gibson RJ Keefe DM | 2006 | Support Care Cancer2006，14，9： | 1 |
| 13 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of torvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Jr Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 14 | The kinet- ics of taxoid accumulation in cell suspension cultures of Taxus following elicitation with methyl jasmonate 显示文摘 | Ketchum REB Gibson DM Croteau RB | 1999 | Bio- technology and Bioengineering1999，62，1： | 1 |
| 15 | Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol显示文摘 | Beg ZH Al mann DW Gibson DM | | 0，，04： | 1 |
| 16 | Direct Vascular and Cardioprotective Effects of Rosuvastatin, a New HMG - CoA Reduc- tase Inhibitor显示文摘 | Jones SP Gibson MF Rimmer DM 3rd | 2002 | Journal of the American College of Cardiology2002，40，6： | 1 |
| 17 | Gastrointestinal mucositis显示文摘 | Keefe DM Gibson R J Hauer-Jensen M | 2004 | Semin Oncol Nuts2004，20，1： | 1 |
| 18 | Mutiple-dose pharmacokinetics, pharmacodinamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects 显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | J Clin Pharmacol1996，60，6： | 1 |
| 19 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，： | 1 |
| 20 | Rapid and automated detection of Salmonella by electrical measurements 显示文摘 | EasterMC Gibson DM | 1985 | Journal of Hygiene1985，94，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员